Loading news...
Series B funding round for CRISPR Therapeutics raising $29M in April 2015
Series B funding round for CRISPR Therapeutics raising $29M in April 2015
| Investor | Firm Type |
|---|
| Partner |
|---|
SR OneLEAD | Venture Capital | — |
| Public | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$127M
Top Valuation
-
CRISPR Therapeutics raised $29M in a Series B round.
The round was announced on 04/01/15.
The round was led by SR One, Celgene.